CardioFocus: CardioFocus, Inc.: CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
1-year results demonstrated 90.2% freedom from atrial arrhythmia in paroxysmal AF patients using CardioFocus' Centauri System with a proprietary monopolar PFA waveform CardioFocus, Inc., a medical...
Read full article »
CEO
CardioFocus is a Massachusetts-based medical device company that manufactures and supplies endoscopic ablation systems for the treatment of atrial fibrillation disorder.
Read more